SEC Comment Letter for NATURES SUNSHINE PRODUCTS INC (NATR) (CIK 0000275053) (NATR) — Apr 11, 2016
NATURES SUNSHINE PRODUCTS INC (NATR) (CIK 0000275053)
Date: April 11, 2016 · CIK: 0000275053 · Accession: 0000000000-16-071587
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-34483
Letter
Mail Stop 4720 April 7, 2016 Gregory L. Probert Chief Executive Officer Nature’s Sunshine Products, Inc. 2500 West Executive Parkway, Suite 100 Lehi, U T 84043
Re: Nature’s Sunshine Products, Inc. Preliminary Proxy Statement on Schedule 14A Filed March 15 , 201 6 File No. 001-34483
Dear Mr. Probert :
We have completed our review of your filing. We remind you that our comment or changes to disclosure in response to our comment do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities la ws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.
Please contact Michael Gershon at (202) 551 -6598 or Joseph McCann at (202) 551-6262 with any questions.
Sincerely,
/s/ Joseph McCann for
Show Raw Text
Mail Stop 4720 April 7, 2016 Gregory L. Probert Chief Executive Officer Nature’s Sunshine Products, Inc. 2500 West Executive Parkway, Suite 100 Lehi, U T 84043 Re: Nature’s Sunshine Products, Inc. Preliminary Proxy Statement on Schedule 14A Filed March 15 , 201 6 File No. 001-34483 Dear Mr. Probert : We have completed our review of your filing. We remind you that our comment or changes to disclosure in response to our comment do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities la ws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Please contact Michael Gershon at (202) 551 -6598 or Joseph McCann at (202) 551-6262 with any questions. Sincerely, /s/ Joseph McCann for Suzanne Hayes Assistant Director Office of Healthcare and Insurance cc: Richard D. Strulson, Esq.